The colonic microflora and probiotic therapy in health and disease

Current Opinion in Gastroenterology

Volumn 27, Issue 1, 2011, Pages 61-65

  Shanahan, Fergus ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Inflammatory bowel disease; Metagenomics; Microbiota; Mucosal immunity; Pharmabiotic

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; CHRONIC INFLAMMATION; COLON FLORA; DIET; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; INTESTINE MUCOSA; LIFESTYLE; METABOLIC DISORDER; NONHUMAN; OBESITY; PATHOGENESIS;

COLON; COLONIC DISEASES; HUMANS; PROBIOTICS;

EID: 79951676804     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328340076f     Document Type: Article

References (51)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573-621.
2. Barrett JC, Lee JC, Lees CW, et al., UK IBD Genetics Consortium. Genomewide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41:1330-1334.
3. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323.
4. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010; 140:859-870.
5. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28:623-667.
6. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65. This is an illumina-based metagenomic sequencing study of faecal samples from 124 European individuals.
7. Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 2010; 107:7503-7508.
8. Hehemann J-H, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010; 464:908-912. An intriguing study indicating that seaweeds with associated marine bacteria may have been the route by which carbohydrate active enzymes were acquired by human gut microbiota and that consumption of dietary-derived bacteria may be a means of generating diversity of the gut microbiota.
9. Mahowald MA, Rey FE, Seedorf H, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A 2009; 106:5859-5864. This is an important study demonstrating the dynamism of the gut ecosystem and the factors influencing interactions amongst the microbiota and changes in host physiology in response to changes in microbial composition.
10. Marques TM, Wall R, Ross RP, et al. Programming infant gut microbiota: Influence of dietary and environmental factors. Curr Opin Biotechnol 2010; 21:149-156.
11. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107:11971-11975. This is an interesting study that establishes a baseline for studies tracking successional development of the human microbiome in different body habitats after different modes of delivery.
12. Claesson MJ, Cusack S, O'Sullivan O, et al. Microbes and Health Sackler Colloquium: Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2010. [Epub ahead of print] This study represents the largest and deepest sampling of the composition of the microbiota in the elderly, to date. It provides a baseline and benchmark for further investigations underway on the influence of diet, drugs and living conditions on the microbiota in the elderly.
13. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5:e10667.
14. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1:6-14.
15. Raoult D. The globalization of intestinal microbiota. Eur J Clin Microbiol Infect Dis 2010; 29:1049-1050.
16. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101:15718-15723. (Pubitemid 39473554)
17. Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 2006; 103:12511-12516. (Pubitemid 44267289)
18. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Design 2009; 15:1546-1558.
19. Vrieze A, Holleman F, Zoetendal EG, et al. The environment within: How gut microbiota may influence metabolism and body composition. Diabetologia 2010; 53:606-613.
20. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137:1716-2240. This is an important study that demonstrates the primacy of diet fat rather than obesity per se as a modifying influence on the composition of the microbiota.
21. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328:228-231. This is a fascinating report linking a deficiency of the innate immune system with changes in the microbiota and development of metabolic disease.
22. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-620.
23. Wall R, Ross RP, Shanahan F, et al. The metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009; 89:1393-1401.
24. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-169.
25. Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-498. Manipulation of this commensal-regulated pathway may offer a new therapeutic opportunity for chronic inflammatory diseases.
26. Round JL, Mazmanian SK. Inducible Foxp3 regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204-12209. This is a provocative report, although other studies have shown that certain other commensals including probiotic organisms have a similar effect.
27. Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33-45. (Pubitemid 47505255)
28. Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206:1883-1897.
29. Erratum in J Exp Med 2009; 206:2301.
30. Knight P, Campbell BJ, Rhodes JM. Host-bacteria interaction in inflammatory bowel disease. Br Med Bull 2008; 88:95-113.
31. Sibartie S, Scully P, Keohane J, et al. Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm Bowel Dis 2010; 16:296-304.
32. Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: An assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009; 104:1162-1169.
33. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3:417-427. (Pubitemid 351773097)
34. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-16736.
35. Schwiertz A, Jacobi M, Frick J-S, et al. Microbiota in pediatric inflammatory bowel disease. J Pediatr 2010; 157:240-244.
36. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141:1135-1145. This study has important implications for understanding gene-environment interactions, environment-environment interactions and the relationship between genotype and phenotype in humans.
37. Ehlers S, Kaufmann SHE. Infection, inflammation, and chronic diseases: Consequences of a modern lifestyle. Trends Immunol 2010; 31:184-190.
38. Rook GAW. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Darwinian medicine and the 'hygiene' or 'old friends' hypothesis. Clin Exp Immunol 2010; 160:70-79.
39. Turnbaugh PJ, Gordon JI. An invitation to the marriage of metagenomics and metabolomics. Cell 2008; 134:708-713.
40. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-894. This is a provocative essay from two titans of the fields of microbiology and infectious disease.
41. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: Ancient history, modern implications. J Clin Invest 2009; 119:2475-2487.
42. Fumagalli M, Pozzoli U, Cagliani R, et al. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009; 206:1395-1408. Self-explanatory in its title, this study raises intriguing implications concerning the loss of ancestral microbes and risk of inflammatory disease.
43. Shanahan F. Gut microbes: From bugs to drugs. Am J Gastroenterol 2010; 105:275-279.
44. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat Rev Microbiol 2010; 8:171-184.
45. Kankainen M, Paulin L, Tynkkynen S, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 2009; 106:17193-17198.
46. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125:921-930. This is an important finding of major clinical significance for these desperately ill patients.
47. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: It is time to change practice. Pediatrics 2010; 125:1068-1070.
48. Soll RF. Probiotics: Are we ready for routine use? Pediatrics 2010; 125:1071-1072.
49. Gao XW, Mubasher M, Fang CY, et al. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636-1641. This is an important trial demonstrating a simple but effective strategy for reducing the risk of antibiotic-associated disease in hospitalized patients.
50. Rea MC, Sit CS, Clayton E, et al. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A 2010; 107:9352-9357.
51. Rea MC, Dobson A, O'Sullivan O, et al. Microbes and Health Sackler Colloquium: Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A 2010. [Epub ahead of print] This is an important example of mining the microbiota for novel drugs, in this case, a narrow spectrum bacteriocin with activity against C. difficile.